miR-10b-5p-mediated upregulation of PIEZO1 predicts poor prognosis and links to purine metabolism in breast cancer
Authors:
Open Access
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Piezo-type mechanosensitive ion channel component 1 (Piezo1) in human cancerBiomedicine & Pharmacotherapy, 2021
- XIAP, commonly targeted by tumor suppressive miR-3607-5p and miR-3607-3p, promotes proliferation and inhibits apoptosis in hepatocellular carcinomaGenomics, 2021
- Piezo1 impairs hepatocellular tumor growth via deregulation of the MAPK-mediated YAP signaling pathwayCell Calcium, 2021
- The function of Piezo1 in colon cancer metastasis and its potential regulatory mechanismJournal of Cancer Research and Clinical Oncology, 2020
- High Expression of Pseudogene PTTG3P Indicates a Poor Prognosis in Human Breast CancerMolecular Therapy-Oncolytics, 2019
- PIEZO1 functions as a potential oncogene by promoting cell proliferation and migration in gastric carcinogenesisMolecular Carcinogenesis, 2018
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival AnalysesNeoplasia, 2017
- Touch, Tension, and Transduction – The Function and Regulation of Piezo Ion ChannelsTrends in Biochemical Sciences, 2017
- miR‐10b*, a master inhibitor of the cell cycle, is down‐regulated in human breast tumoursEMBO Molecular Medicine, 2012
- Role of Purine Metabolism in Regulation of Signal Transduction in Human Carcinoma Cells1998